Pharmacogenomic Testing in Antidepressant Drug Therapy
common.study.values.description
“Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy”
A randomized controlled trial comparing pharmacogenomic guided versus standard pharmacist care to optimize antidepressant drug therapy. This study evaluates the effectiveness of pharmacists utilizing pharmacogenomic testing in the community pharmacy setting to help patients find the most appropriate drug therapy option(s) and minimize the risk of side effects in collaboration with prescribing physicians.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Pharmacogenomic Testing
pharmacogenomic drug response test provides personalized insights on a patient's predicted response to medications based on metabolism
Pharmacist Standard of Care
Pharmacist providing standard of care as per usual practice
participant.views.study.view.additional
participant.views.study.view.scientific-title
A Randomized Controlled Trial of Pharmacogenomic Guided Versus Standard Pharmacist Care to Optimize Antidepressant Drug Therapy in a Community Pharmacy Setting
common.study.values.clinical-trial-id
NCT03591224
participant.views.study.view.id
egJJGd
